Reta Peptide Chemical Name: What 'Reta' Stands For and How It Is Identified

By What Peptides Editorial Team · Updated 2026-09-14 · Part of Peptide Handling Guides: Reconstitution Arithmetic, Storage and Testing

'reta' is not a chemical name. It is shorthand that developed in online discussion forums and seller listings for retatrutide, an investigational peptide that acts on three receptors at once: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor and the glucagon receptor. Because the shorthand is short, it has spread into places where precision matters, including listing titles and casual comparisons between compounds. This page explains how research peptides are formally identified, what each identifier is good for, and how to check that a shorthand label and a formal name refer to the same molecule. It is educational content and is not medical advice.

Retatrutide is an investigational compound. It is not approved by the US Food and Drug Administration, the European Medicines Agency or the UK Medicines and Healthcare products Regulatory Agency, and it is not a consumer product or a dietary supplement. Where it appears outside a clinical trial it is typically sold as a research material labelled research use only and not for human consumption, which is a statement about the terms of sale rather than a description of what the substance is or does. Nothing here recommends obtaining it, and nothing here describes any use in humans or animals.

What 'Reta' Actually Refers To

The molecule is a peptide built on a glucagon-like peptide-1 backbone with modifications that let it engage more than one receptor and persist longer in circulation. Published descriptions place it in the class of multi-receptor agonists: like tirzepatide, which acts at GIP and GLP-1 receptors, retatrutide adds activity at the glucagon receptor. It carries a lipid-modified side chain, a fatty diacid attached through a linker to a lysine residue, which promotes binding to serum albumin and slows clearance. This is the same broad strategy used for several long-acting peptide medicines. The molecular mass is commonly quoted in the region of 4.7 kilodaltons, although any reader should confirm the exact figure on the certificate for the batch in front of them.

During development, compounds carry code names rather than names. Retatrutide's development code, which appears in trial registrations and early publications, is LY-3437943, with the LY prefix indicating the originating company. Code names are assigned before any nonproprietary name exists and they persist in the literature long afterwards, which is why a search for the formal name sometimes misses the primary research. A reader comparing two documents may find one referring to LY-3437943 and another to retatrutide; both point at the same molecule only if the sequence and mass also agree, and that is the check which actually settles the question. The same problem arises in a more extreme form in the comparison of informal seller labels.

The Identifier Families, and What Each Is For

An International Nonproprietary Name, or INN, is the generic name assigned through the World Health Organization's nomenclature programme. The system uses stems to signal relatedness, and the -tide stem marks a peptide, while other parts of the name indicate the class. The INN is the name used in prescribing information and regulatory documents once a medicine is approved, and it is the most stable human-readable identifier a compound has. A United States Adopted Name, where one exists for the US market, usually matches the INN. Neither name describes the structure, though: they are labels, not descriptions, and two quite different molecules can sit in the same stem family.

A CAS Registry Number is a numeric identifier assigned by the Chemical Abstracts Service to a specific substance, formatted as three groups of digits separated by hyphens, with a check digit at the end. It solves the problem that one substance can have many names and one name can be used loosely, and it is the best single key for searching databases and literature. Critically, a number is assigned per substance as registered, so different salt forms, different counter-ions and different solvates can carry different numbers, which matters a great deal for a peptide supplied as a trifluoroacetate salt. The sequence is the most fundamental identifier of all, since it is the structure itself, and the molecular mass derived from it is the check that ties everything together.

Identifier types and what each is good for
Identifier typeWhat it looks likeWhat it is good for
INN or generic nameretatrutide, ending in the -tide stemReading regulatory and clinical documents
Development codeLY-3437943Finding trial registrations and early publications
CAS Registry NumberThree digit groups with a final check digitUnambiguous database and literature searching
Amino acid sequenceOrdered residue letters, with modifications notedConfirming what the molecule actually is
Molecular formula and massElement counts and a mass in daltonsChecking a measured mass spectrum against theory
Shorthand or forum labelreta, and similar clipped formsNothing verifiable; treat it as a search term only

How to Check That Two Names Describe One Molecule

The comparison is a short checklist and all four items should agree. First, the sequence: not just the residue letters but the modifications, since a lipid side chain on a lysine changes both the mass and the behaviour substantially, and it is frequently omitted from informal sequence strings. Second, the molecular mass, which should match the value calculated from the sequence including modifications, to within the tolerance of the instrument. Third, the CAS number, read from a certificate rather than from a listing. Fourth, the counter-ion and salt form, because a trifluoroacetate salt and an acetate salt of the same peptide are different substances with different masses and typically different registry entries.

Where those checks cannot be run, the honest answer is that identity has not been established. A listing that gives a shorthand name, no sequence, no CAS number and no batch-matched certificate provides nothing to verify against, and the reader is being asked to take the seller's word. Where a certificate does exist, the identity claim should be supported by mass spectrometry rather than merely asserted, and the distinction between what each method proves is set out in the purity testing methods comparison. For the structural vocabulary used above, see how a peptide is defined, and for the wider practical set, the peptide guides collection. This page is educational, is not medical advice, and makes no claim about any product.

Frequently asked questions

Is reta the same as retatrutide?

In ordinary online usage, yes: reta is community shorthand for retatrutide, an investigational triple-agonist peptide. Shorthand is not an identifier, though. Two listings both using the word reta may describe different material, so confirm the sequence, the molecular mass and the CAS number rather than trusting the label alone.

What is retatrutide's CAS number?

A CAS Registry Number has been assigned to retatrutide, but read it from the certificate of analysis for the specific batch rather than from a forum post or a listing, because salt forms and counter-ions can carry different numbers. The certificate is the document that ties the number to the material in the vial.

Is retatrutide approved as a medicine?

No. Retatrutide is described publicly as an investigational compound in clinical development rather than an approved medicine, and it is not a supplement or a consumer product. Any decision about a prescription medicine belongs with a licensed clinician working from approved prescribing information.

Related reading

Sources & further reading

  1. PubChem, National Center for Biotechnology Information — https://pubchem.ncbi.nlm.nih.gov/
  2. ClinicalTrials.gov, US National Library of Medicine — https://clinicaltrials.gov/
  3. World Health Organization — https://www.who.int/
WP
What Peptides Editorial Team — peptide reference content written and fact-checked in-house against public sources. Every figure is traced to a cited reference; see our editorial process. Last reviewed 2026-09-14.

This page is part of the Peptide Handling Guides: Reconstitution Arithmetic, Storage and Testing guide.

Questions about method, arithmetic or sourcing on this page? Message the editorial desk.